More Than a Document: How Collaboration Shapes Clinical Study Protocols and Informed Consent Forms

More Than a Document: How Collaboration Shapes Clinical Study Protocols and Informed Consent Forms:

Clinical study designs are developed based on scientific rationale, participant safety, regulatory expectations, and study objectives. Once a study design is established, it must be translated into clear clinical trial documents that can be understood and used by different audiences.

The clinical study protocol serves as a practical guide for the teams responsible for conducting the research. It outlines how the study should be performed and helps ensure that study procedures are followed consistently. In contrast, the informed consent form (ICF) is written for potential participants. It explains key study information in participant-friendly language so that individuals can understand what participation may involve before deciding whether to take part.

Scientific medical writers lead the development and writing of clinical study protocols and ICFs. However, these documents are not created by the writer alone. They are developed through a systematic and organized process involving the Sponsor, the Principal Investigator, scientific medical writers, and other research professionals involved in the study, including Clinic, Pharmacy, Screening and Recruiting, Biostatistics, Pharmacokinetics, Clinical Data Management, and the Bioanalytical Laboratory, as applicable.

Throughout this process, the scientific medical writer helps coordinate the flow of information amongst these groups. This includes gathering input, clarifying requirements, aligning comments, and making sure that all feedback from the Sponsor and study teams is carefully considered and incorporated. This collaborative approach helps ensure that the final documents accurately reflect the study objectives while supporting participant safety and clear study conduct.

The Protocol as a Shared Roadmap: 

A clinical study protocol does more than describe the scientific design of a study; it also serves as a shared roadmap for the entire study team. It describes the purpose of the study, who may participate, what procedures will be performed, how participant safety will be monitored, and how study results will be evaluated.

For a protocol to be effective, it must be scientifically sound, operationally feasible, and clear enough to be followed consistently. This requires input from different areas of expertise. Scientific inputs, including pharmacokinetic and pharmacodynamic considerations as applicable, help to shape the study design in alignment with applicable regulatory expectations. Clinical operations provide insight into whether planned procedures can be performed safely and efficiently. Recruitment and screening teams help assess whether the eligibility criteria and study requirements are practical for potential participants. Bioanalytical, data management and statistical teams provide important input on sample handling, data generation, and analysis. The Principal Investigator provides medical oversight to support participant safety and clinical appropriateness.

When these perspectives are brought together and are in alignment, the protocol becomes more than a written plan. It becomes a common reference point that helps the study team understand the study in the same way and conduct it with consistency.

The ICF as a Participant-Focused Document:

While the protocol guides the study team, the ICF is designed for potential participants. Its purpose is to explain the study in language that is clear, accurate, and understandable. This allows individuals to make an informed decision about whether they wish to participate.

The ICF explains why the study is being conducted, what will happen during participation, how long participation may last, what risks or discomforts may occur, and what rights participants have. It also describes important topics such as confidentiality, compensation, voluntary participation, and the right to withdraw from the study.

Developing an ICF requires more than simplifying the protocol. It requires careful judgment to present study information in a way that is complete but not overwhelming, accurate but not overly technical, and accessible to a wide audience.

This process is also strengthened by feedback from participant-facing teams, such as Clinical Operations and Recruitment. These teams interact directly with participants and understand the types of questions or concerns that may arise during the study process. When this feedback is communicated and incorporated, it helps support the continuous improvement of participant-facing documents. As a result, ICFs can become clearer, more practical, and easier to understand.

A strong ICF supports transparency, participant understanding, and trust in the clinical research process.

The Role of the Scientific Medical Writer:

Scientific medical writers play a central role in connecting the scientific design, operational requirements, sponsor expectations, regulatory considerations, and participant-facing information. Their role is not simply to write the protocol or ICF. They also help organize information, identify gaps, clarify inconsistencies, align input from different teams, and translate complex requirements into clear and usable documents.

This requires an understanding of both the scientific and operational aspects of clinical research. For example, a sampling schedule must support the scientific objective of the study, but it must also be feasible for the clinic team to perform. Safety monitoring procedures must protect participants, but they must also be described clearly enough for the study team to understand when and how assessments should occur. Eligibility criteria must support the study design, while also being written in a way that screening and recruitment teams can apply consistently.

By reviewing these details as connected parts of the same study, scientific medical writers help reduce ambiguity, improve consistency, and support smoother study conduct.

Sponsor Feedback as an Essential Part of the Process: 

Sponsor involvement is an essential part of protocol and ICF development. The Sponsor brings important knowledge about the investigational product, study objectives, development strategy, regulatory expectations, and overall scientific rationale. Sponsor feedback helps ensure that the documents accurately reflect the intended purpose of the study and the information needed to support the research.

During document development, Sponsor comments and requests are carefully reviewed and incorporated as appropriate. This collaborative exchange helps refine the protocol and ICF, clarify study requirements, and keep the final documents aligned with the Sponsor’s expectations and the needs of the study.

This process is especially important when study details evolve. Changes may be needed based on scientific review, feasibility considerations, regulatory or ethics committee feedback, safety considerations, or operational planning. When communication between the Sponsor and study teams is clear and organized, updates can be made more efficiently and accurately.

Collaboration in Action at BioPharma Services Inc.

At BioPharma Services Inc. (BPSI), protocol and ICF development is supported by close collaboration between the sponsor, Scientific Medical Writers, Clinical Operation teams, Scientists, and other research professionals involved in the study. This collaborative approach helps ensure that study requirements are clearly understood, consistently communicated, and practically implemented across the research process.

Strong clinical research depends on alignment. When the appropriate teams are involved during document development, the protocol can guide study conduct more clearly. At the same time, the ICF can better support transparency, participant understanding, and informed decision-making.

High-quality clinical research documents are not just the product of good writing. They are the product of good teamwork. At BPSI, the development of protocols and ICFs reflects a coordinated effort to support scientific quality, operational efficiency, participant understanding, and successful clinical research.

Written By:

HanHee Lee, PhD